ATEC
Alphatec Holdings, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$8.27
+10.64%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 839.7M | 764.2M | 611.6M | 482.3M | 350.9M |
| Cost of Revenue | 279.6M | 232.3M | 187.3M | 172.1M | 117.8M |
| Gross Profit | 560.1M | 531.9M | 424.3M | 310.2M | 233.1M |
| Operating Expenses | |||||
| R&D Expense | 76.5M | 76.3M | 80.7M | 70.1M | 44.0M |
| SG&A Expense | 517.0M | 498.5M | 450.2M | 374.1M | 300.0M |
| General & Admin Expense | 132.5M | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | (6.8M) | 39.2M | 29.5M | 39.4M | 36.0M |
| Total Operating Expenses | 586.2M | 614.0M | 560.4M | 483.6M | 380.0M |
| Cost and Expenses | 865.8M | 846.3M | 747.7M | 655.7M | 497.8M |
| Operating Income (EBIT) | (26.1M) | (82.1M) | (136.2M) | (173.4M) | (147.0M) |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 38.5M | 21.1M | 24.9M | 16.6M | 5.5M |
| Net Interest Income | (38.5M) | (21.1M) | (24.9M) | (16.6M) | (5.5M) |
| Other Non-Op Income/Expense | (62.6M) | (61.3M) | (25.9M) | (13.5M) | (5.0M) |
| Non-Operating Income (excl Interest) | 24.1M | 40.1M | 1.0M | (3.1M) | (471.0K) |
| EBT (Pre-Tax Income) | (88.7M) | (143.4M) | (162.1M) | (186.9M) | (152.0M) |
| Income Tax Expense | (1.8M) | (45.0K) | 50.0K | (277.0K) | (716.0K) |
| Bottom Line | |||||
| Net Income | (86.9M) | (143.4M) | (162.1M) | (186.6M) | (151.3M) |
| Earnings from Cont. Ops | (86.9M) | (143.4M) | (162.1M) | (186.6M) | (151.3M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (86.9M) | (143.4M) | (162.1M) | (186.6M) | (151.3M) |
| Per Share | |||||
| Basic EPS | ($0.56) | ($0.96) | ($1.13) | ($1.54) | ($1.47) |
| Diluted EPS | ($0.56) | ($0.96) | ($1.13) | ($1.54) | ($1.47) |
| Revenue Per Share | $5.34 | $5.09 | $4.28 | $3.98 | $3.39 |
| Shares | |||||
| Basic Shares Outstanding | 157.4M | 150.1M | 142.9M | 121.2M | 103.4M |
| Diluted Shares Outstanding | 157.4M | 150.1M | 142.9M | 121.2M | 103.4M |
| Profitability Metrics | |||||
| EBITDA | 32.3M | (39.7M) | (53.9M) | (110.6M) | (102.6M) |
| D&A | 82.5M | 82.6M | 83.3M | 59.7M | 43.9M |
| EBIT | (50.2M) | (122.3M) | (137.2M) | (170.3M) | (146.5M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026